Immediate Impact

1 by Nobel laureates 8 from Science/Nature 63 standout
Sub-graph 1 of 24

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
CAR T Cells and T-Cell Therapies for Cancer
2024 Standout
2 intermediate papers

Works of Iris Isufi being referenced

Total Costs of Care during Chimeric Antigen Receptor T-Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: A Large Private Insurance Claim-Based Analysis
2022
Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results from a Phase 1 Study
2018

Author Peers

Author Last Decade Papers Cites
Iris Isufi 154 263 116 142 59 499
Xuejun Chen 99 157 119 113 36 521
Siba El Hussein 163 143 98 91 66 466
Sumie Tabata 138 134 68 110 49 428
Udomsak Bunworasate 219 206 154 130 51 503
Mariko Yabe 197 141 134 111 39 451
Gilad Itchaki 169 216 248 150 40 534
Eri Matsuki 131 244 122 130 39 471
Michio Sawada 299 204 91 151 37 571
Daisuke Miura 137 150 79 42 59 453
Hiromi Koiso 139 71 106 127 44 414

All Works

Loading papers...

Rankless by CCL
2026